Douglas Liu, Senior Vice President Global Operations at QIAGEN, joins Rich Bendis on the inaugural podcast of BioTalk with Rich Bendis. This new podcast series features conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. Learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.
Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, said in a regulatory filing it has raised $65 million in an ongoing equity financing round in which it hopes to raise $111.5 million.
University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) will work under a formal collaboration with the Frederick National Laboratory for Cancer Research (operated by Leidos Biomedical Research, Inc.) to explore new candidate vaccines against human papillomavirus (HPV), a common cause of cervical cancer.
University of Maryland, state and local officials will gather to dedicate A. James Clark Hall, the university’s new engineering facility that will transform the region’s biotech corridor. Media will be able to tour the 184,000-square-foot building and see the state-of-the-art bioengineering facilities where students from one of the university’s fastest growing degree programs will spark innovations in human health. A. James Clark Hall will serve as a hub for new bioengineering partnerships and collaborations throughout the Baltimore-Washington region.
Gov. Larry Hogan plans to ask state lawmakers to set standards for computer science training in public schools, one of several steps he says will help create a more tech-savvy workforce in Maryland.
College of Southern Maryland in La Plata is set to open a new 20,000-square-foot research and education facility, backed by over $1 million in funding.
Join us on November 17th at 11 a.m. for the Mid-Atlantic Biology Research and Career (MABRC) Network’s Career Counselor Conference & Networking Event in Baltimore County.
Our Keynote speaker will be Kelly M. Schulz, Secretary of the Maryland Department of Labor, Licensing and Regulation (DLLR).
Incyte Corp. is expanding its clinical collaboration with MedImmune, AstraZeneca’s global biologics research and development arm.
As part of the expanded agreement, the two companies will evaluate the effectiveness and safety of a combination therapy — featuring one product from each company — in treating patients with non-small cell lung cancer.
Million Women Mentors-Maryland (MWM·MD) is addressing the underrepresentation of women in the STEM fields by building an expansive network of mentors throughout the state. Since its founding in 2017, the organization has worked to identify individual and corporate partners whose experience and knowledge positively influence young female students to pursue and persist in STEM careers. This year, MWM·MD has already surpassed its goal of 5,000 mentors, and is now pledging to secure 10,000 mentors by the end of 2017. To kick off this effort, MWM·MD is inviting individual mentors and corporate sponsors who want to learn more about mentoring to its Nov. 6 summit in Baltimore.
The University of Maryland, Baltimore (UMB) plays a role in three of the six teams that successfully competed for three-quarters of a million dollars from the Maryland Technology Development Corporation (TEDCO) to support incubator ideas.
The Johns Hopkins Social Innovation Lab announced its 2017-18 cohort Thursday, introducing the 10 promising nonprofit ventures that will receive business and financial support over the next six months. From November through April, these 10 fledgling startups will receive funding, mentorship, training, and office space to help them develop into sustainable ventures.
Danaher has acquired IDBS, a U.K.-based scientific informatics company, to round out its life sciences portfolio. The company hopes that IDBS’ data management, analytics and modeling platforms will accelerate the pace of drug discovery and development.
Thank you for attending, participating, and supporting TEDCO’s Entrepreneur Expo and Stem Cell Symposium. If you’ve already taken the survey, THANK YOU! If not, please help us make the event better by providing your feedback! At the end of this brief survey, you can access photos from the 2017 event.
Are you interested in leading innovation within an established company or creating your own startup company?
Explore the online Master of Professional Studies (MPS) in Technology Entrepreneurship at the University of Maryland. Applications for the spring 2018 entering class are due by December 15, 2017.
TEDCO offers an Executive Exchange Program that provides for temporary or “loaned” executives to help lead a startup for up to nine months, and executive coaching to train entrepreneurs to lead their own firms.
Betamore and Sagamore Ventures hosted the third Beta City Sept. 28 at City Garage as part of Build Baltimore, a two-day initiative that brought together Baltimore-area change makers to shine a light on those who are shaping the future of the city.
Researchers at Stanford University are developing a linear accelerator that is the size of a chip — instead of two miles long — and it could herald a medical breakthrough. Linear accelerators are commonly used for external beam radiation treatments for patients with cancer. However, only a handful have been constructed as they are very expensive to build, maintain and operate. Stanford’s accelerator on a chip could provide every hospital with access to this life-saving technology.
It’s easy to think, from the headlines, that the future of health care is being forged on Capitol Hill. But the traditional centers of power and influence are losing ground — and talent — to the fertile, sometimes chaotic, environs of Silicon Valley.
Will you be among the first to pick your kids’ IQ? As machine learning unlocks predictions from DNA databases, scientists say parents could have choices never before possible.
“Precision medicine gives us the chance to marry what’s unique about America – our spirit of innovation, our courage to take risks, our collaborative instincts – with what’s unique about Americans – every individual’s distinctive genetic makeup, lifestyles, and health needs. In doing so, we can keep ourselves, our families, and our nation healthier for generations to come.”
The Biotechnology Innovation Organization (BIO) today released a set of priorities for unleashing the power of innovation to develop solutions to prescription opioid abuse and addiction.
